Enlightify (NYSE: ENFY) falls below NYSE $1 minimum, plans cure

Q: How is Enlightify Inc. responding to the NYSE notice?

Enlightify Inc. informed the NYSE by a September 9, 2025 letter that it intends to cure the share price deficiency so it can return to compliance with the continued listing standard.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)

Form Type

8-K

Rhea-AI Filing Summary

Enlightify Inc. received notice from the New York Stock Exchange that the 30‑trading‑day average closing price of its common stock fell below $1.00 per share, which is the minimum average share price required for continued listing under NYSE Rule 802.01C. This places the company out of compliance with one of the NYSE’s continued listing standards.

The company informed the NYSE by letter dated September 9, 2025 of its intent to cure this share price deficiency so it can regain compliance with the listing requirement. Enlightify’s common stock continues to trade on the NYSE under the symbol ENFY while it works to address the issue.

Positive

None.

Negative

NYSE price-based noncompliance: Enlightify Inc. is out of compliance with the NYSE’s $1.00 minimum 30‑day average share price requirement for continued listing under Rule 802.01C.

Insights

Enlightify faces NYSE minimum price noncompliance but plans to cure it.

Enlightify Inc. has been notified that its 30‑day average closing price fell below $1.00 per share, triggering noncompliance with NYSE Rule 802.01C. This rule requires listed common stocks to maintain at least a $1.00 average closing price over 30 trading days to remain in good standing.

The company has told the NYSE, via a September 9, 2025 letter, that it intends to cure this share price deficiency. Common cure approaches in such situations can include operational improvements or corporate actions, but specific measures are not described in the excerpt. Actual outcomes will depend on whether the stock price recovers sufficiently to satisfy the NYSE’s continued listing standard.

8-K Event Classification

2 items: 3.01, 9.01

2 items

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Securities

The company received a delisting notice or transferred its listing to a different exchange.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Understanding 8-K Material Events →

09/10/2025 - 05:10 PM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 27, 2025

Enlightify Inc.

(Exact name of Registrant as specified in charter)

Nevada	001-34260	36-3526027
(State or other jurisdiction	(Commission File No.)	(IRS Employer
of Incorporation)		Identification No.)

3^rdFloor, Borough A, Block A.

No.181 South Taibai Road

Xi’an, Shaanxi Province

People’s Republic of China 710065

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: +86-29-88266368

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17CFR230.425)

☐	Soliciting material pursuant to Rule14a-12 under the Exchange Act (17CFR240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock		ENFY		NYSE

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

As previously reported, on August 27, 2025, the New York Stock Exchange (“NYSE”) notified Enlightify Inc. (the “Company”) that the 30-trading-day average closing price of the Company’s common stock had fallen below $1.00 per share, the minimum average share price required for continued listing of the Company’s common stock on the NYSE under Rule 802.01C of the NYSE Listed Company Manual.

Pursuant to applicable NYSE rules, the Company has responded to the NYSE by letter of September 9, 2025 informing the NYSE of its intent to cure the share price deficiency for the purpose of returning to compliance with the continued listing standard.

Item 9.01. Financial Statements and Exhibits.

(d)

Exhibits.

Exhibit No.		Description
99.1		Press Release dated September 10, 2025
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: September 10, 2025	ENLIGHTIFY INC.
	(Registrant)

	By:	/s/ Zhuoyu Li
		Zhuoyu Li
		Chairman of the Board of Directors, Chief Executive Officer, and President

Source: View Original Filing on SEC EDGAR

FAQ

What NYSE issue did Enlightify Inc. (ENFY) disclose?

Enlightify Inc. disclosed that the New York Stock Exchange notified the company that its 30‑trading‑day average closing price for common stock fell below $1.00 per share, breaching the NYSE’s minimum price requirement for continued listing under Rule 802.01C.

What is the NYSE listing standard Enlightify (ENFY) failed to meet?

The company failed to meet the NYSE requirement that a listed common stock maintain at least a $1.00 per share average closing price over a 30‑trading‑day period, as set out in Rule 802.01C of the NYSE Listed Company Manual.

How is Enlightify Inc. responding to the NYSE notice?

Enlightify Inc. informed the NYSE by a September 9, 2025 letter that it intends to cure the share price deficiency so it can return to compliance with the continued listing standard.

Is Enlightify Inc. still listed on the NYSE after this notice?

Yes. The filing states that Enlightify Inc. received notice of noncompliance due to its average price falling below $1.00, but it describes an intention to cure the deficiency; the common stock remains listed on the NYSE under the symbol ENFY while the company works to regain compliance.

Does the 8-K mention any specific actions Enlightify (ENFY) will take to cure the deficiency?

The disclosure states that Enlightify Inc. has notified the NYSE of its intent to cure the share price deficiency, but it does not describe specific actions in the provided excerpt.